A phase I trial of taxol given by a 6-hour intravenous infusion
Brown, T, Havlin, K, Weiss, G, Cagnola, J, Koeller, J, Kuhn, J, Rizzo, J, Craig, J, Phillips, J, Von Hoff, D
Published in Journal of clinical oncology (01.07.1991)
Published in Journal of clinical oncology (01.07.1991)
Get more information
Journal Article
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
O'Rourke, T.J., Brown, T.D., Havlin, K., Kuhn, J.G., Craig, J.B., Burris, H.A., Satterlee, W.G., Tarassoff, P.G., Von Hoff, D.D.
Published in European journal of cancer (1990) (1994)
Published in European journal of cancer (1990) (1994)
Get full text
Journal Article
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer
HAVLIN, K. A, RAMIREZ, M. J, LEGLER, C. M, HARRIS, L. N, MATULONIS, U. A, HOHNEKER, J. A, HAYES, D. F, WINER, E. P
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
Phase I clinical investigation of amonafide
Saez, R, Craig, J B, Kuhn, J G, Weiss, G R, Koeller, J, Phillips, J, Havlin, K, Harman, G, Hardy, J, Melink, T J
Published in Journal of clinical oncology (01.09.1989)
Published in Journal of clinical oncology (01.09.1989)
Get more information
Journal Article
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
Body, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., Bergström, B.
Published in Annals of oncology (01.09.2003)
Published in Annals of oncology (01.09.2003)
Get full text
Journal Article
Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm
BURSTEIN, Harold J, HARRIS, Lyndsay N, RYAN, Paula D, ELLIS, Mathew J, NUNES, Raquel A, BUNNELL, Craig A, CAMPOS, Susana M, HALLOR, Michele, GELMAN, Rebecca, WINER, Eric P, MARCOM, P. Kelly, LAMBERT-FALLS, Rosemary, HAVLIN, Kathleen, OVERMOYER, Beth, FRIEDLANDER, Robert J, GARGIULO, Janet, STRENGER, Rochelle, VOGEL, Charles L
Published in Journal of clinical oncology (01.08.2003)
Published in Journal of clinical oncology (01.08.2003)
Get full text
Journal Article
Phase I clinical and pharmacokinetic trial of flavone acetic acid
Havlin, K A, Kuhn, J G, Craig, J B, Boldt, D H, Weiss, G R, Koeller, J, Harman, G, Schwartz, R, Clark, G N, Von Hoff, D D
Published in JNCI : Journal of the National Cancer Institute (16.01.1991)
Published in JNCI : Journal of the National Cancer Institute (16.01.1991)
Get more information
Journal Article
Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?
Olowokure, O. O., Beg, M. S., Ali, S., Tandra, A., Safa, M. M., Havlin, K., Ahmad, S. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study
Havlin, K A, Kuhn, J G, Koeller, J, Boldt, D H, Craig, J B, Brown, T D, Weiss, G R, Cagnola, J, Phillips, J, Harman, G
Published in Anti-cancer drugs (01.04.1995)
Published in Anti-cancer drugs (01.04.1995)
Get more information
Journal Article
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule
Brown, T D, O'Rourke, T J, Kuhn, J G, Craig, J B, Havlin, K, Burris, 3rd, H A, Cagnola, J, Hamilton, J M, Grindey, G B, Satterlee, W G
Published in Anti-cancer drugs (01.04.1994)
Published in Anti-cancer drugs (01.04.1994)
Get more information
Journal Article
Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule
VON HOFF, D. D, KUHN, J. G, WARGIN, W, HUBBELL, J, TUTTLE, R. L, KOELLER, J. M, FREEMAN, G. L, HAVLIN, K. A, LANGEVIN, A.-M, BROWN, T. D, WEISS, G. R, TURNER, J. N, PURVIS, J, SOL LUCAS, V, BAIR, K. W
Published in Cancer research (Chicago, Ill.) (01.12.1990)
Get full text
Published in Cancer research (Chicago, Ill.) (01.12.1990)
Journal Article
A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia
Rodriguez, G, Brown, T D, Balis, F M, Craig, J B, Denham, C A, Kuhn, J G, Havlin, K, Von Hoff, D D
Published in Anti-cancer drugs (01.04.1993)
Published in Anti-cancer drugs (01.04.1993)
Get more information
Journal Article
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators
Havlin, K A, Kuhn, J G, Craig, J B, Weiss, G R, Koeller, J, Turner, J N, Luther, J S, Clark, G, Bair, K W, Wargin, W
Published in Anti-cancer drugs (01.08.1991)
Published in Anti-cancer drugs (01.08.1991)
Get more information
Journal Article
Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy
Demark-Wahnefried, W, Hars, V, Conaway, MR, Havlin, K, Rimer, BK, McElveen, G, Winer, EP
Published in The American journal of clinical nutrition (01.05.1997)
Published in The American journal of clinical nutrition (01.05.1997)
Get full text
Journal Article
Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis
Wagner, L. I., Sweet, J. J., Butt, Z., Beaumont, J., Havlin, K. A., Sabatino, T., Cella, D.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
New anticancer agents
Brown, T D, Burris, H A, Havlin, K A, O'Rourke, T J, Rodriguez, G I, Wall, J G, Weiss, G R
Published in Cancer chemotherapy and biological response modifiers (1991)
Get more information
Published in Cancer chemotherapy and biological response modifiers (1991)
Journal Article